212 related articles for article (PubMed ID: 9363836)
1. Future developments in the treatment of immune-mediated polyneuropathies.
van der Meché FG; van Doorn PA
Eur Neurol; 1997; 38(3):230-7. PubMed ID: 9363836
[TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.
van der Meché FG; van Doorn PA
Ann Neurol; 1995 May; 37 Suppl 1():S14-31. PubMed ID: 8968214
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of chronic relapsing inflammatory demyelinating polyradiculoneuropathy: combination of corticosteroids, plasma exchange, and intravenous immunoglobulins.
Briellmann RS; Nydegger UE; Sturzenegger M; Fierz L; Hess CW; Hauser SP
Eur Neurol; 1998; 39(3):190-1. PubMed ID: 9605400
[No Abstract] [Full Text] [Related]
4. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
5. Immune mediated neuropathies--an update on therapeutic strategies.
Czaplinski A; Steck AJ
J Neurol; 2004 Feb; 251(2):127-37. PubMed ID: 14991345
[TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: pathogenesis and treatment.
Koski CL
Semin Neurol; 1994 Jun; 14(2):123-30. PubMed ID: 7984827
[No Abstract] [Full Text] [Related]
7. [Treatment of chronic immune-mediated polyneuropathies. State of the art and perspectives].
Léger JM; Chassande B
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S19-23. PubMed ID: 10896984
[TBL] [Abstract][Full Text] [Related]
8. A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies.
Pollard JD
Muscle Nerve; 1987; 10(3):214-21. PubMed ID: 3031499
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies.
Comi G; Nemni R; Amadio S; Galardi G; Leocani L
Mult Scler; 1997 Apr; 3(2):93-7. PubMed ID: 9291161
[TBL] [Abstract][Full Text] [Related]
10. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies.
Lehmann HC; Hartung HP
J Neuroimmunol; 2011 Feb; 231(1-2):61-9. PubMed ID: 21056913
[TBL] [Abstract][Full Text] [Related]
11. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
Soueidan SA; Dalakas MC
Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases.
Stangel M; Toyka KV; Gold R
Arch Neurol; 1999 Jun; 56(6):661-3. PubMed ID: 10369303
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of action of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy.
Brand A; Van Doorn PA; Rossi F; Kazatchkine MD; Vermeulen M
Prog Clin Biol Res; 1990; 337():405-9. PubMed ID: 2353004
[No Abstract] [Full Text] [Related]
14. Modulating the immune response in demyelinating diseases.
Hughes R
J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):148. PubMed ID: 9489519
[No Abstract] [Full Text] [Related]
15. Treatment of immune-mediated inflammatory neuropathies.
Hadden RD; Hughes RA
Curr Opin Neurol; 1999 Oct; 12(5):573-9. PubMed ID: 10590894
[TBL] [Abstract][Full Text] [Related]
16. [Recent advances of immune therapies for demyelinating neuropathies].
Ito H; Saito T
Rinsho Shinkeigaku; 1997 Dec; 37(12):1111-2. PubMed ID: 9577661
[TBL] [Abstract][Full Text] [Related]
17. Guillain-Barré as an autoimmune disease.
Shoenfeld Y; George J; Peter JB
Int Arch Allergy Immunol; 1996 Apr; 109(4):318-26. PubMed ID: 8634515
[TBL] [Abstract][Full Text] [Related]
18. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.
Dyck PJ; Litchy WJ; Kratz KM; Suarez GA; Low PA; Pineda AA; Windebank AJ; Karnes JL; O'Brien PC
Ann Neurol; 1994 Dec; 36(6):838-45. PubMed ID: 7998769
[TBL] [Abstract][Full Text] [Related]
19. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
Tracy JA; Dyck PJ
Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
[TBL] [Abstract][Full Text] [Related]
20. Rational therapy of Guillain-Barré syndrome.
Samman I; Wöhrle JC; Hennerici M
Lancet; 1998 Mar; 351(9104):753-4. PubMed ID: 9504543
[No Abstract] [Full Text] [Related]
[Next] [New Search]
